Active, not recruitingPhase 4NCT05209035

Evaluation of Trazodone in OSA-MCI

Studying Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese University of Hong Kong
Principal Investigator
Timothy CY Kwok
Chinese University of Hong Kong
Intervention
Trazodone(drug)
Enrollment
134 target
Eligibility
60-80 years · All sexes
Timeline
20222026

Study locations (1)

Collaborators

Hong Kong University of Science and Technology

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05209035 on ClinicalTrials.gov

Other trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

Additional recruiting or active studies for the same condition.

See all trials for Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome

← Back to all trials